Tabula Rasa HealthCare Company Profile: Involvement on Pharmacogenomic and Personalized Medicine Research

Tabula Rasa HealthCare (TRHC), a leader in medication safety research and parent company of CareVention HealthCare, is profiled in the online journal Future Medicine. With medication-related problems predicted to account for 4.6 million hospitalizations and 150,000 premature deaths by 2030, TRHC is developing systems to help clinicians reduce inappropriate medication use and enable safer prescribing. Read more about TRHC’s research and science-informed technology below.